These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6112931)

  • 1. Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction.
    Hegardt B; Pauwels R; Van Der Straeten M
    Allergy; 1981 Feb; 36(2):115-22. PubMed ID: 6112931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New beta-agonist, KWD 2131, compared with terbutaline in asthmatics. A cumulative dose-response study.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):105-12. PubMed ID: 6104451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Jul; 35(5):413-9. PubMed ID: 6108726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immediate- and late-response inhibition of a new beta-agonist, KWD 2131, compared with terbutaline and DSCG.
    Hegardt B; Pauwels R; Van der Straeten M
    Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():283-5. PubMed ID: 6796524
    [No Abstract]   [Full Text] [Related]  

  • 5. The protective property of equipotent bronchodilating doses of inhaled KWD 2131 and terbutaline against allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N; Granerus G
    Allergy; 1982 Aug; 37(6):407-16. PubMed ID: 7137535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine-induced bronchospasm. Its reproducibility and usage in clinical evaluation of the sub-threshold bronchodilating dose of a new beta-agonist, KWD 2131.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):113-21. PubMed ID: 6104452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the inhibition of allergen-induced intracutaneous reactions by a new beta-agonist, KWD 2131, and by terbutaline.
    Hegardt B; Arner B
    Eur J Respir Dis; 1981 Oct; 62(5):352-9. PubMed ID: 6124440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the bronchodilating and antiallergic properties of a beta-adrenoceptor stimulant, KWD 2131, in asthmatic patients.
    Pegelow KO; Strandberg K
    Allergy; 1980 Sep; 35(6):509-19. PubMed ID: 6110383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between ketotifen and DSCG in bronchial challenge.
    Pauwels R; Lamont H; Van Der Straeten M
    Clin Allergy; 1978 May; 8(3):289-93. PubMed ID: 97033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotonic nebulized disodium cromoglycate provides better protection against methacholine- and exercise-induced bronchoconstriction.
    Weiner P; Saaid M; Reshef A
    Am Rev Respir Dis; 1988 Jun; 137(6):1309-11. PubMed ID: 3144199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid reversibility of the allergen-induced pulmonary late-phase reaction by an intravenous beta2-agonist.
    Peebles RS; Permutt S; Togias A
    J Appl Physiol (1985); 1998 May; 84(5):1500-5. PubMed ID: 9572791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical bronchoconstriction with nebulized albuterol but not with terbutaline.
    Finnerty JP; Howarth PH
    Am Rev Respir Dis; 1993 Aug; 148(2):512-3. PubMed ID: 8342917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic modulation of bronchial hyperreactivity.
    Lowhagen O
    Eur J Respir Dis Suppl; 1982; 117():97-120. PubMed ID: 6807704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of treatment with formoterol on bronchoprotection against methacholine.
    Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
    Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
    Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
    Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with disodium cromoglycate does not alter bronchial hyperreactivity in patients with perennial bronchial asthma.
    Haber P; Geyer K; Burghuber OC
    Respiration; 1989; 55(1):44-9. PubMed ID: 2500688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind evaluation of nebulized cromolyn, terbutaline, and the combination for childhood asthma.
    Shapiro GG; Furukawa CT; Pierson WE; Sharpe MJ; Menendez R; Bierman CW
    J Allergy Clin Immunol; 1988 Feb; 81(2):449-54. PubMed ID: 3123540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of regular terbutaline on the airway response to inhaled budesonide.
    Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
    Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Thorax; 1998 Feb; 53(2):110-3. PubMed ID: 9624295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.